{"organizations": [], "uuid": "eb3573a197c47927e7b59d2a36b7069d057b93d3", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-insys-therapeutics-addresses-new-y/brief-insys-therapeutics-addresses-new-york-ags-complaint-idUSFWN1PR1D8", "country": "US", "domain_rank": 408, "title": "BRIEF-Insys Therapeutics Addresses New York AG's Complaint", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-02T06:06:00.000+02:00", "replies_count": 0, "uuid": "eb3573a197c47927e7b59d2a36b7069d057b93d3"}, "author": "", "url": "https://www.reuters.com/article/brief-insys-therapeutics-addresses-new-y/brief-insys-therapeutics-addresses-new-york-ags-complaint-idUSFWN1PR1D8", "ord_in_thread": 0, "title": "BRIEF-Insys Therapeutics Addresses New York AG's Complaint", "locations": [], "entities": {"persons": [], "locations": [{"name": "new york", "sentiment": "none"}], "organizations": [{"name": "brief-insys therapeutics addresses new york ag", "sentiment": "negative"}, {"name": "brief-insys therapeutics addresses new york ag's complaint reuters", "sentiment": "neutral"}, {"name": "insys therapeutics inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 1 (Reuters) - Insys Therapeutics Inc:\n* INSYS THERAPEUTICS ADDRESSES NEW YORK ATTORNEY GENERAL‘S COMPLAINT\n* INSYS THERAPEUTICS - ‍INTEND TO CONTINUE WORKING COLLABORATIVELY WITH ALL RELEVANT AUTHORITIES TO RESOLVE OUTSTANDING GOVERNMENTAL INVESTIGATIONS​ Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-02-02T06:06:00.000+02:00", "crawled": "2018-02-02T06:19:53.013+02:00", "highlightTitle": ""}